NVS - MorphoSys jumps amid report Novartis in advanced talks to takeover
2024-02-05 10:24:24 ET
More on MorphoSys
- MorphoSys: Positive Pelabresib Data Finally Unlocking Upside
- MorphoSys: A Buying Opportunity Following Mixed Phase 3 Results In Myelofibrosis
- MorphoSys: Buying Constellation Was A Desperate Measure
- MorphoSys expects 2024 Monjuvi U.S. net product sales in $80M - $95M range
- MorphoSys gains amid takeover speculation